Research and Markets, one of the world’s leading market research firms, has identified NADMED as one of the fastest-growing clinical laboratory tests in Europe over the next five years.
The molecular diagnostics segment, a key area of focus, is projected to achieve a compound annual growth rate (CAGR) exceeding 5% during the forecast period, showcasing significant expansion within the industry.
NADMED stands out among 30 prominent vendors in the market, alongside industry leaders like Synlab and Labcorp. This recognition underscores NADMED’s pivotal role across key B2B market areas and its growing influence in the consumer sector.
These insights are part of the Europe’s Clinical Laboratory Tests Market Forecast to 2029, offering an in-depth analysis of emerging trends and market dynamics. Read more here.